CompletedNot Applicable

Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy

United States60 participantsStarted 2018-07-18

Plain-language summary

This study compares the yield of 19-gauge needles vs 21-gauge needles during EBUS TBNA procedures.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years or older * Able to provide informed consent * Referred for EBUS TBNA sampling at Regions Hospital Exclusion Criteria: * On therapeutic warfarin, Plavix, or ticagrelor in the past 5 days * INR\>1.8 or platelets \<50K

What they're measuring

Diagnostic Yield

Timeframe: 6 months

Diagnostic Yield

Timeframe: 6 months

Trial details

NCT IDNCT03657849

SponsorHealthPartners Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01-25

Results submitted2021-09-16

View on ClinicalTrials.gov More Enlarged Lymph Nodes (Excluding Infective) trials